Toxic Epidermal Necrolysis  >>  Kenketsu Glovenin-I (normal human immunoglobulin IV)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kenketsu Glovenin-I (normal human immunoglobulin IV) / Takeda
NCT01696500: Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Completed
3
10
Japan
Intravenous immunoglobulin
Nihon Pharmaceutical Co., Ltd
Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis
06/14
06/14

Download Options